Intra-Cellular Therapies Inc.

Thank you for standing by and welcome to the Intracellular Therapies 3Q 2023 Earnings Conference Call. At this time, all participants are on a listen-only mode. After the speaker's presentations, there will be a question and answer session. To answer the question, please press star 11 on your telephone. Please be advised that today's call is being recorded. I would like to turn the call over to your host, Dr. Juan Sanchez, Head of Investor Relations at ITCI.

Please go ahead, sir.

Good morning and thank you all for being here. Joining me on the call today are Dr. Chowdhan Maid, Chairman and Chief Executive Officer, Mark Newman, Chief Commercial Officer, Dr. Suresh Dorgan, Chief Medical Officer, and Larry Heinlein, Chief Financial Officer. As a reminder, during today's call, we will be making certain forward-looking statements. These forward-looking statements are based on current information assumptions, and expectations. Those are subject to change and involve a number of risks and uncertainties that may cause actual results to differ materially from those contained in the forward-looking statements. These and other risks are described in our periodic filings made with the Securities and Exchange Commission, including our quarterly and annual reports. You are cautioned not to place undue reliance on these forward-looking statements and the company disclaims any obligations to obey such statements. I will now turn the call over to Sharon. Sharon?